Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Microbiome Therapeutics
1.2 Key Market Segments
1.2.1 Microbiome Therapeutics Segment by Type
1.2.2 Microbiome Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Microbiome Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Microbiome Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Microbiome Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Microbiome Therapeutics Market Competitive Landscape
3.1 Global Microbiome Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Microbiome Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Microbiome Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Microbiome Therapeutics Sales Sites, Area Served, Product Type
3.6 Microbiome Therapeutics Market Competitive Situation and Trends
3.6.1 Microbiome Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Microbiome Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Microbiome Therapeutics Industry Chain Analysis
4.1 Microbiome Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Microbiome Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Microbiome Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Microbiome Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Microbiome Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Microbiome Therapeutics Price by Type (2019-2024)
7 Microbiome Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Microbiome Therapeutics Market Sales by Application (2019-2024)
7.3 Global Microbiome Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Microbiome Therapeutics Sales Growth Rate by Application (2019-2024)
8 Microbiome Therapeutics Market Segmentation by Region
8.1 Global Microbiome Therapeutics Sales by Region
8.1.1 Global Microbiome Therapeutics Sales by Region
8.1.2 Global Microbiome Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Microbiome Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Microbiome Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Microbiome Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Microbiome Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Microbiome Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Seres Therapeutics
9.1.1 Seres Therapeutics Microbiome Therapeutics Basic Information
9.1.2 Seres Therapeutics Microbiome Therapeutics Product Overview
9.1.3 Seres Therapeutics Microbiome Therapeutics Product Market Performance
9.1.4 Seres Therapeutics Business Overview
9.1.5 Seres Therapeutics Microbiome Therapeutics SWOT Analysis
9.1.6 Seres Therapeutics Recent Developments
9.2 Assembly Biosciences
9.2.1 Assembly Biosciences Microbiome Therapeutics Basic Information
9.2.2 Assembly Biosciences Microbiome Therapeutics Product Overview
9.2.3 Assembly Biosciences Microbiome Therapeutics Product Market Performance
9.2.4 Assembly Biosciences Business Overview
9.2.5 Assembly Biosciences Microbiome Therapeutics SWOT Analysis
9.2.6 Assembly Biosciences Recent Developments
9.3 Synthetic Biologics
9.3.1 Synthetic Biologics Microbiome Therapeutics Basic Information
9.3.2 Synthetic Biologics Microbiome Therapeutics Product Overview
9.3.3 Synthetic Biologics Microbiome Therapeutics Product Market Performance
9.3.4 Synthetic Biologics Microbiome Therapeutics SWOT Analysis
9.3.5 Synthetic Biologics Business Overview
9.3.6 Synthetic Biologics Recent Developments
9.4 Interxon
9.4.1 Interxon Microbiome Therapeutics Basic Information
9.4.2 Interxon Microbiome Therapeutics Product Overview
9.4.3 Interxon Microbiome Therapeutics Product Market Performance
9.4.4 Interxon Business Overview
9.4.5 Interxon Recent Developments
9.5 PureTech
9.5.1 PureTech Microbiome Therapeutics Basic Information
9.5.2 PureTech Microbiome Therapeutics Product Overview
9.5.3 PureTech Microbiome Therapeutics Product Market Performance
9.5.4 PureTech Business Overview
9.5.5 PureTech Recent Developments
9.6 Synlogic
9.6.1 Synlogic Microbiome Therapeutics Basic Information
9.6.2 Synlogic Microbiome Therapeutics Product Overview
9.6.3 Synlogic Microbiome Therapeutics Product Market Performance
9.6.4 Synlogic Business Overview
9.6.5 Synlogic Recent Developments
9.7 Enterome BioScience
9.7.1 Enterome BioScience Microbiome Therapeutics Basic Information
9.7.2 Enterome BioScience Microbiome Therapeutics Product Overview
9.7.3 Enterome BioScience Microbiome Therapeutics Product Market Performance
9.7.4 Enterome BioScience Business Overview
9.7.5 Enterome BioScience Recent Developments
9.8 4D Pharma
9.8.1 4D Pharma Microbiome Therapeutics Basic Information
9.8.2 4D Pharma Microbiome Therapeutics Product Overview
9.8.3 4D Pharma Microbiome Therapeutics Product Market Performance
9.8.4 4D Pharma Business Overview
9.8.5 4D Pharma Recent Developments
9.9 Second Genome
9.9.1 Second Genome Microbiome Therapeutics Basic Information
9.9.2 Second Genome Microbiome Therapeutics Product Overview
9.9.3 Second Genome Microbiome Therapeutics Product Market Performance
9.9.4 Second Genome Business Overview
9.9.5 Second Genome Recent Developments
9.10 AOBiome
9.10.1 AOBiome Microbiome Therapeutics Basic Information
9.10.2 AOBiome Microbiome Therapeutics Product Overview
9.10.3 AOBiome Microbiome Therapeutics Product Market Performance
9.10.4 AOBiome Business Overview
9.10.5 AOBiome Recent Developments
9.11 C3 Jian
9.11.1 C3 Jian Microbiome Therapeutics Basic Information
9.11.2 C3 Jian Microbiome Therapeutics Product Overview
9.11.3 C3 Jian Microbiome Therapeutics Product Market Performance
9.11.4 C3 Jian Business Overview
9.11.5 C3 Jian Recent Developments
9.12 Rebiotix
9.12.1 Rebiotix Microbiome Therapeutics Basic Information
9.12.2 Rebiotix Microbiome Therapeutics Product Overview
9.12.3 Rebiotix Microbiome Therapeutics Product Market Performance
9.12.4 Rebiotix Business Overview
9.12.5 Rebiotix Recent Developments
9.13 MicroBiome Therapeutics LLC
9.13.1 MicroBiome Therapeutics LLC Microbiome Therapeutics Basic Information
9.13.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Overview
9.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Market Performance
9.13.4 MicroBiome Therapeutics LLC Business Overview
9.13.5 MicroBiome Therapeutics LLC Recent Developments
9.14 Metabiomics
9.14.1 Metabiomics Microbiome Therapeutics Basic Information
9.14.2 Metabiomics Microbiome Therapeutics Product Overview
9.14.3 Metabiomics Microbiome Therapeutics Product Market Performance
9.14.4 Metabiomics Business Overview
9.14.5 Metabiomics Recent Developments
9.15 Ritter Pharmaceuticals
9.15.1 Ritter Pharmaceuticals Microbiome Therapeutics Basic Information
9.15.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Overview
9.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Product Market Performance
9.15.4 Ritter Pharmaceuticals Business Overview
9.15.5 Ritter Pharmaceuticals Recent Developments
9.16 Symberix
9.16.1 Symberix Microbiome Therapeutics Basic Information
9.16.2 Symberix Microbiome Therapeutics Product Overview
9.16.3 Symberix Microbiome Therapeutics Product Market Performance
9.16.4 Symberix Business Overview
9.16.5 Symberix Recent Developments
9.17 OpenBiome
9.17.1 OpenBiome Microbiome Therapeutics Basic Information
9.17.2 OpenBiome Microbiome Therapeutics Product Overview
9.17.3 OpenBiome Microbiome Therapeutics Product Market Performance
9.17.4 OpenBiome Business Overview
9.17.5 OpenBiome Recent Developments
9.18 Azitra
9.18.1 Azitra Microbiome Therapeutics Basic Information
9.18.2 Azitra Microbiome Therapeutics Product Overview
9.18.3 Azitra Microbiome Therapeutics Product Market Performance
9.18.4 Azitra Business Overview
9.18.5 Azitra Recent Developments
9.19 Symbiotix Biotherapies
9.19.1 Symbiotix Biotherapies Microbiome Therapeutics Basic Information
9.19.2 Symbiotix Biotherapies Microbiome Therapeutics Product Overview
9.19.3 Symbiotix Biotherapies Microbiome Therapeutics Product Market Performance
9.19.4 Symbiotix Biotherapies Business Overview
9.19.5 Symbiotix Biotherapies Recent Developments
9.20 Osel
9.20.1 Osel Microbiome Therapeutics Basic Information
9.20.2 Osel Microbiome Therapeutics Product Overview
9.20.3 Osel Microbiome Therapeutics Product Market Performance
9.20.4 Osel Business Overview
9.20.5 Osel Recent Developments
9.21 Metabogen
9.21.1 Metabogen Microbiome Therapeutics Basic Information
9.21.2 Metabogen Microbiome Therapeutics Product Overview
9.21.3 Metabogen Microbiome Therapeutics Product Market Performance
9.21.4 Metabogen Business Overview
9.21.5 Metabogen Recent Developments
10 Microbiome Therapeutics Market Forecast by Region
10.1 Global Microbiome Therapeutics Market Size Forecast
10.2 Global Microbiome Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Microbiome Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Microbiome Therapeutics Market Size Forecast by Region
10.2.4 South America Microbiome Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Microbiome Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Microbiome Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Microbiome Therapeutics by Type (2025-2030)
11.1.2 Global Microbiome Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Microbiome Therapeutics by Type (2025-2030)
11.2 Global Microbiome Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Microbiome Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Microbiome Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings